Table 2.
Demographic and clinical characteristics of study patients (ITT data set)
| Variables | Ganciclovir in situ ophthalmic gel (n = 108) | Ganciclovir ophthalmic gel (n = 111) | P-value |
|---|---|---|---|
| Sex, n (%) | 0.2106 | ||
| Male | 70 (64.81) | 63 (56.76) | |
| Female | 38 (35.19) | 48 (43.24) | |
| Age, mean ± SD, years | 43.83 ± 13.37 | 44.54 ± 12.15 | 0.6997 |
| Chinese race, n (%) | 108 (100.0) | 111 (100.0) | |
| Physical examination, n (%) | 0.5853 | ||
| Normal | 107 (99.07) | 109 (98.20) | |
| Abnormal | 1 (0.93) | 2 (1.80) | |
| Allergy history, n (%) | 0.2705 | ||
| Negative | 98 (90.74) | 105 (94.59) | |
| Positive | 10 (9.26) | 6 (5.41) | |
| TSI of the baseline, mean ± SD | 17.75 ± 5.71 | 17.98 ± 5.45 | 0.6782 |
| Baseline VA | |||
| Mean ± SD | 0.50 ± 0.26 | 0.54 ± 0.27 | 0.2970 |
Abbreviations: ITT, intent-to-treat; n, number; SD, standard deviation; TSI, total scores of clinical indicators; VA, visual acuity.